Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma

Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma

Abstract Hepatocellular carcinoma (HCC) is the leading cause of cancer-related death worldwide, because recurrence often occurs in most HCC patients undergoing hepatectomy. It is necessary to identify patients with high risk for recurrence and adopt effective therapies. An obstacle to monitor patien...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Binghua Li, Wendu Feng, Ouyang Luo, Tiancheng Xu, Yajuan Cao, Hongyan Wu, Decai Yu, Yitao Ding
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/00143853c4ef4ec2ba9214ccd9394d38
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares